title: Peptide Developability at the Discovery-to-Development Interface--Current State and Future Opportunities.
authors.affiliation: Merck & Co, Discovery Pharmaceutical Sciences, Kenilworth, New Jersey, 07081, USA, annette_bak@merck.com.
authors.forename: Annette
authors.initials: A
authors.lastname: Bak
authors.forename: Weiguo
authors.initials: W
authors.lastname: Dai
mesh_terms: D000818:Animals; D017277:Drug Approval; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D010455:Peptides / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D015202:Protein Engineering / Q000379:methods*
chemical_list: D010455:Peptides
references.citation: AAPS J. 2015 Jan;17(1):134-43
references.pmid: 25366889
references.citation: AAPS J. 2015 Jan;17(1):111-20
references.pmid: 25338742
references.citation: AAPS J. 2015 Jan;17(1):144-55
references.pmid: 25398427